GRAND RAPIDS, Mich., July 14, 2025 (Newswire.com) – Sixty percent of counties in the U.S. do not have a single psychiatrist, and 77 percent report a severe shortage, according to a 2022 study in Psychiatric Times. Primary care clinicians often have to fill this gap, but only 10-30 percent of them say they are comfortable diagnosing attention-deficit/hyperactivity disorder (ADHD) in adults. Mentavi Health offers a clinically validated diagnostic assessment for the diagnosis of ADHD in adults that closes the psychiatric care gap quickly, easily, and at an accessible price.

Mentavi Health is recognized as an innovator and national leader in online mental health diagnosis and treatment. Founded in 2018 as ADHD Online, Mentavi Health now provides a broad spectrum of services, from mental wellness checks to diagnosis and treatment.

The Mentavi Diagnostic Evaluation provides critical support to primary care clinicians, in particular those whose patients are seeking diagnosis and treatment for ADHD or other mental disorders. Patients can complete the self-paced online evaluation on their own, without a clinician present. It takes one to two hours to complete, and assesses for mental health concerns including anxiety, ADHD, and depression. The cost is less than $200.

A licensed, doctorate-level psychologist reviews the assessment responses and renders a diagnosis to the patient and designated provider in five days or less. The diagnosis can be used to develop a treatment plan, which can include medication (as warranted), coaching, and therapy with a Mentavi clinician or the patient’s own healthcare provider.

“Primary care clinicians are becoming increasingly important in adult ADHD care, but they often lack the time, tools, and resources needed to accurately diagnose the condition,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “Clinically validated asynchronous assessments and telehealth clinicians, as available on the Mentavi Health platform, can provide primary care clinicians with this evidence-based, accessible resource for their patients.”

Research conducted by Mentavi and presented at the 10th World Congress on ADHD in Prague, Czech Republic, validated the accuracy and reliability of the Mentavi Diagnostic Evaluation for diagnosing ADHD in adults, when compared with traditional face-to-face, in-person clinical assessments that are typically the standard of care in the field. A publication of the study results in a peer-reviewed journal is expected in the next few months.

Among the study’s findings:

• The Mentavi Diagnostic Evaluation and the clinical interview have a diagnostic agreement of 78%.
• The Mentavi Diagnostic Evaluation has a Positive Predictive Value (PPV) of 94.9%
• The Mentavi Diagnostic Evaluation identifies ADHD-positive cases more accurately than the clinical interview, with a 12% false positive rate vs. 56% for the clinical interview.
• The Mentavi Diagnostic Evaluation is more conservative than the clinical interview, meaning it does not over-diagnose ADHD in adults.

The Mentavi Diagnostic Evaluation is based on the latest research and practices. It was developed using more than a dozen validated screening instruments and specific questions aligned with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria to diagnose a broad range of mental health conditions, including ADHD. Study results demonstrate that an online asynchronous assessment, such as the Mentavi Health tool, is a reliable, accurate, and trusted tool for diagnosing ADHD in adults.

“As value-based care becomes the norm, primary care teams need scalable tools that deliver measurable impact,” said Keith Brophy, CEO of Mentavi Health. “Our diagnostic solution helps practices identify and treat mental health conditions earlier, supporting better patient outcomes and stronger performance on quality metrics.”

Mentavi Health’s core mission is to increase access to accurate, efficient, and evidence-based mental health assessments. With ADHD in adults significantly underdiagnosed and undertreated, the Mentavi Diagnostic Evaluation will aid clinicians with their role in the diagnosis and treatment of this and related disorders.

For more information, visit Mentavi Health or ADHD Online.

About Mentavi Health
Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

GRAND RAPIDS, MI AND SANTA BARBARA, CA, October 29, 2025 (Newswire.com) – Santa Barbara City College (SBCC) is adopting Mentavi Health‘s Diagnostic Evaluation to provide timely, rigorous ADHD assessments for students seeking academic accommodations. The partnership enables SBCC to reach accommodation decisions faster, when appropriate, and helps students stay on course during the term’s most demanding weeks.

ADHD is the second-largest eligibility category for SBCC’s Disability Services and Programs for Students (DSPS). Until now, many students have faced weeks-long waits for off-campus diagnostic appointments-delays that can impede access to federally mandated accommodations under the Americans with Disabilities Act (ADA) and Section 504.

With Mentavi’s asynchronous online Diagnostic Evaluation, students can complete a thorough assessment in about 60-90 minutes and receive results, reviewed by a licensed, doctorate-level clinician, within five days. The process reduces turnaround time from weeks to days, while meeting clinical standards for documentation required by DSPS.

“Early identification and treatment of ADHD and related mental-health conditions is crucial for improved academic and personal outcomes,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “Timely diagnosis enables students to access the accommodations and support they need to succeed.”

Mentavi’s Diagnostic Evaluation, the first online ADHD assessment for adults to be clinically validated against current standards of care, has already served more than a dozen higher-education institutions nationwide and completed over 20,000 college-student evaluations. The validation study was published September 8, 2025, in the Journal of Clinical Psychiatry (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

“For many of our students, the greatest challenge isn’t the classroom itself but the invisible barriers that delay the accommodations they are entitled to under federal law,” said Jana M. Garnett, DSPS Coordinator and Director at SBCC. “Mentavi makes professional clinical diagnoses both accessible and affordable, providing a pathway to the support our students need to thrive.”

Efficient and Affordable Support

Students complete Mentavi’s evaluation online and can share their report with SBCC’s DSPS office to determine accommodations or with a Mentavi clinician for follow-up therapy, medical treatment, or coaching. Each evaluation is reviewed by a licensed clinician-not by automated AI-and is available for $189, a fraction of the cost of typical in-person assessments.

Mentavi’s model helps colleges and universities expand student mental-health support without overburdening campus clinics or budgets, while giving students rapid access to evidence-based care.

Enhancing Student Outcomes and Institutional Reputation

Early, accurate diagnosis equips students to adopt strategies that improve academic performance and personal well-being. By facilitating timely access to care, as indicated by diagnosis, SBCC underscores its commitment to student success and equity.

“With national discussions underway about ADHD treatments and with growing state-level scrutiny of AI in healthcare, Mentavi stands out by combining validated evaluations with a human-centered model,” said Keith Brophy, CEO of Mentavi Health. “Every evaluation is reviewed by a licensed clinician, ensuring accuracy and accountability while reducing stress on families, faculty, and staff.”

About Santa Barbara City College

Established in 1909, Santa Barbara City College (SBCC) is one of the oldest community colleges in California. The district consists of SBCC’s main campus on Santa Barbara’s beachfront coast, two separate campuses for its School of Extended Learning programs, as well as a Cosmetology school. The college offers a range of associate degree, certificate and transfer programs and is recognized by the Department of Education as an official Hispanic-Serving Institution (HSI). One of SBCC student success programs includes the Disability Services and Programs for Students (DSPS). SBCC DSPS ensures educational access through accommodations, services, and support that help students with disabilities achieve their academic goals. Learn more at SBCC.edu.

About Mentavi Health

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

Media contact:

Tim Cox, ZingPR for Mentavi Health
tim@zingpr.com

GRAND RAPIDS, Mich., October 1, 2025 (Newswire.com) – Quintessence Psychiatry, a telepsychiatry practice led by Nona Kocher, MPH, MD, has adopted Mentavi Health‘s asynchronous Diagnostic Evaluation to offer patients a scientifically rigorous, accessible alternative to full neuropsychological testing. The Mentavi Diagnostic Evaluation is clinically validated (and now peer-reviewed and published in the The Journal of Clinical Psychiatry*) for the diagnosis of ADHD in adults.

Quintessence Psychiatry previously referred ADHD inquiries to external neuropsychology providers – a process that can involve weeks to months of waiting and hundreds of dollars in testing costs for a broad battery of tests many patients don’t need. Early experiences at Quintessence show patients can complete the self-directed evaluation at their convenience (often at home) and return to the clinic with a report reviewed by a licensed psychologist to guide treatment conversations.

“Mentavi gives my patients a focused, evidence-based ADHD evaluation at a price and speed they can actually use,” said Dr. Nona Kocher, psychiatrist and founder of Quintessence Psychiatry. “It adds rigor to my workflow and helps patients understand what the findings mean, so we can move forward with an informed plan rather than sending them into a lengthy outside testing queue.”

In the initial phase of adoption, three patients have completed the evaluation, with positive feedback on the clarity of the results and visuals. Patients typically review the Mentavi report with Dr. Kocher at a follow-up visit to discuss how ADHD symptoms may be affecting daily life and to consider therapy and/or medication options. “The report graphics make it easier for patients to grasp their results at a glance, which improves shared decision making,” Dr. Kocher added.

Beyond speed and accessibility, the Mentavi Diagnostic Evaluation integrates cleanly into Quintessence’s care model, which emphasizes applying modern, science-based methods – including, when appropriate, pharmacogenetic testing – to reduce trial and error in treatment selection.

“We are pleased that our validated diagnostic approach can serve Quintessence Psychiatry by removing barriers to timely access to care for their patients. This is what our approach was designed for,” said Keith Brophy, CEO of Mentavi Health.

“Clinicians like Dr. Kocher tell us Mentavi helps them triage ADHD inquiries efficiently and focus their time where it matters most – on individualized care,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. “We’re pleased to support private practices with an evaluation that is clinically validated, rigorous, patient-friendly, and easy to fold into existing workflows.”

Quintessence intends to continue offering the Mentavi Diagnostic Evaluation for appropriate ADHD cases and to gather ongoing patient feedback to inform clinical workflows.

* Peer‑reviewed validation: Results of Mentavi’s diagnostic validation study were published in The Journal of Clinical Psychiatry on September 8, 2025 (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

About Quintessence Psychiatry

Quintessence Psychiatry is a patient-centered telepsychiatry practice led by Nona Kocher, MD, offering comprehensive evaluations, medication management, and individualized care plans. The practice integrates modern, evidence-based methods to help patients move from assessment to actionable next steps. For more information, visit quintessencepsychiatry.com.

About Mentavi Health

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, and compliant online mental health care, grounded in clinical validation and trust. For more information, visit mentavi.com.

Contact Information

Tim Cox 
ZingPR for Mentavi
tim@zingpr.com

Source: Mentavi Health

RELATED MEDIA

GRAND RAPIDS, MICHIGAN / ACCESS Newswire / September 25, 2025 / As the back-to-school season begins, the strain of transition extends beyond students to parents, professors, and staff. Limited campus resources often mean long waits for ADHD, anxiety, or depression evaluations, delaying care and harming academic performance.

Mentavi Health‘s clinically validated, asynchronous Diagnostic Evaluation – the first online assessment for adult ADHD validated against the current standard of care and now peer-reviewed and published in the Journal of Clinical Psychiatry – reduces waits from weeks to days, giving students timely answers when they matter most.

“Early identification and treatment of ADHD and related mental health conditions is crucial for improved clinical outcomes,” said Mentavi Health Chief Medical Officer Barry K. Herman, M.D., MMM. Timely diagnosis allows students to access the right accommodations and support to stay on track academically and personally.

Mentavi now serves more than a dozen higher-education institutions nationwide and has completed over 20,000 student evaluations, demonstrating both the scalability of its services and the value institutions place on timely, validated mental health support. Publication in the Journal of Clinical Psychiatry, one of the field’s leading peer-reviewed journals, further underscores Mentavi’s commitment to scientific rigor and expanding evidence-based access to care.

“For many of our students, the greatest challenge isn’t the classroom itself but the invisible barriers that prevent them from accessing the accommodations they are entitled to under federal law,” said Jana Garnett, DSPS Coordinator/Director at Santa Barbara City College. “By making professional diagnoses accessible and affordable, Mentavi gives our students a pathway to the support they need to persist and succeed in college.”

Efficient and affordable support

Students can complete the Diagnostic Evaluation independently in one to two hours. Each evaluation is reviewed by a licensed, doctorate-level clinician – not automated AI – with results delivered within five days. Students may then share their results with the appropriate offices at their college or university to discuss accommodations or treatment options when warranted.

Alternatively, in over 40 states, students can choose to meet with a Mentavi clinician to explore therapy, medical treatment, or coaching. This flexibility allows institutions to either keep students within their own health systems or to expand support through Mentavi’s nationwide network. At $189 per evaluation, Mentavi’s service is also far more affordable than traditional in-clinic assessments.

Improved student outcomes and institutional reputation

Early and accurate diagnosis empowers students to understand their challenges, access the right support, and adopt strategies that improve performance, strengthen retention, and build adaptability for life after graduation. For institutions, providing timely answers demonstrates a commitment to student well-being and reduces the risk of students falling behind.

“With national discussions underway about stimulant and non-stimulant treatments, and with increasing state-level scrutiny of AI in healthcare, Mentavi stands out by combining validated assessments with a human-centered model: every evaluation is reviewed by a licensed clinician, ensuring accuracy and accountability,” said Keith Brophy, CEO of Mentavi Health.

“Our mission has always been to make clinically validated mental health care accessible and affordable. As the new school year begins, higher-education institutions seek proven ways to support their students while managing limited resources. By partnering with Mentavi, colleges and universities can offer timely, evidence-based diagnosis and care as appropriate that reduces the stress families, faculty, and staff feel during this critical transition period.”

For more information, visit Mentavi Health or ADHD Online. The Mentavi Health Diagnostic Evaluation is clinically validated for the diagnosis of ADHD in adults. Study results were published in the Journal of Clinical Psychiatry on September 8, 2025 (J Clin Psychiatry 2025;86(3):25m15846; doi:10.4088/JCP.25m15846).

About Mentavi Health and ADHD Online

Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of mental health services. With the mission to make high-quality ADHD assessments accessible to all, Mentavi has grown to address not only ADHD but also the most common related mental health conditions. The nationwide Mentavi Mental Health Diagnostic Evaluation and various treatment options showcase the company’s commitment to providing comprehensive, accessible, compliant online mental health care. For more information, visit mentavi.com.

Media contact:

Tim Cox, ZingPR for Mentavi Health tim@zingpr.com

GRAND RAPIDS, Mich., January 25, 2024 (Newswire.com) – Mentavi Health, a leading healthcare provider focused on mental health care and a pioneer in telehealth services through ADHD Online, is proud to announce the expansion of its offerings to include Mental Wellness Coaching nationwide.

This enhancement is a testament to the company’s dedication to delivering diverse and accessible mental health care solutions tailored to the unique needs of patients in a digital-first world.

“We are thrilled to launch Mental Wellness Coaching at the start of the new year, recognizing the varied needs of our thousands of customers,” remarked Keith Brophy, CEO of Mentavi Health. “This addition signifies our dedication to embracing and addressing the diverse wellness journeys of our clients.”

This new service offered nationwide is a testament to Mentavi Health’s commitment to innovation
and patient-centric online care. It is designed to complement the company’s existing suite of services,
providing an alternative for those seeking guidance beyond traditional therapy or supplementing
medical treatment.

Mentavi’s approach to Mental Wellness Coaching is rooted in evidence-based practices and aims to
foster sustainable engagement and positive health outcomes. Based on patient needs, Mental
Wellness Coaching can address various areas such as personal growth, stress management, career
guidance, and goal setting, providing a supportive virtual environment for clients’ development and
skill enhancement. It can also provide a focus on ADHD coaching.

This initiative aligns with the mission of Mentavi Health and ADHD Online to provide accessible and
quality mental health care to everyone, regardless of location. Mentavi Health continues to set the
standard in online mental health services, making strides in offering comprehensive, accessible, and
innovative care solutions. For more information about Mental Wellness Coaching and other services, please visit the company website at https://adhdonline.com/mental-wellness-coaching/.

About Mentavi Health and ADHD Online
Established as ADHD Online in 2018, Mentavi Health has evolved to encompass a broader range of
mental health services. With the mission to make quality ADHD assessments accessible to all,
Mentavi has grown to address not only ADHD but also adjacent mental health conditions. The
nationwide Mentavi Diagnostic Evaluation and various treatment options showcase the company’s commitment to comprehensive, accessible, compliant online mental health care.

GRAND RAPIDS, Mich., January 9, 2024 (Newswire.com) – As colleges and universities deal with budget constraints, Mentavi Health, which pioneered telehealth services through ADHD Online, is partnering with the institutions’ student health centers to provide mental health services and help all students succeed academically.
As mental health care becomes better understood, higher education institutions are facing a growing demand for mental health services from students with ADHD, anxiety, depression and other issues.

That increased demand comes when financial resources are more limited, forcing student health
services to outsource mental health assessments – often with wait times of six to nine months for inperson appointments.

That can mean students are unable to receive diagnoses and begin treatments until the next semester or even the next academic year, placing their academic success in jeopardy.
By working with Mentavi Health, colleges and universities have a way to connect students with timely and cost-effective diagnoses and treatments.

“We partner closely with the care team within the student health centers at our partner institutions. On many campuses, we are happy to complete assessments and render diagnoses and then refer students back to the colleges’ health services to develop proper treatment plans based on our findings,” said Tim Gutwald, Vice President of Business Outreach at Mentavi Health. “This way, the institution can maintain control over how medications are being prescribed and administered on campus, and the student can minimize their out-of-pocket costs for appropriate medical treatment.”

Working with Mentavi provides other benefits for both students and institutions.
Students with untreated ADHD are three times more likely to drop out before they graduate. Colleges understand that neurodiverse students contribute to the campus environment and can be incredibly
successful if given the proper support. As colleges seek to attract those students, Mentavi can help them provide the accommodations students need for success. Mentavi’s “Diagnostic Evaluation” is being
used by multiple colleges within their classroom accommodation process.
Mentavi’s expert assessments can be crucial for students’ health.
Students often exhibit symptoms that sound like ADHD but also sound like anxiety or depression. It requires a clinical expert to help
identify which of these highly related conditions is affecting a student, and a proper treatment plan must consider the source of the symptoms to be effective.

“A simple six-question survey that looks like it comes out of a magazine will not give a psychologist enough information to make this determination,” Gutwald said. “Our Diagnostic Evaluation is designed to draw out more details to ensure our psychologists can identify what conditions are involved. We want it to be simple and easy, but we think it should take longer to complete a mental health assessment than it takes to order a burrito online.”

Mentavi strikes a necessary balance with its clinician-designed Diagnostic Evaluation system: It is easy to complete, and Mentavi delivers results based on the sound clinical evaluation by its licensed psychologists in days instead of weeks or months.
Mentavi also helps students access mental health care by making assessments, diagnosis and treatment affordable.

“Traditional off-campus assessments may cost thousands of dollars, even after
any health insurance contributions,” Gutwald said.

“In general, the cost of our Diagnostic Evaluation is extremely competitive compared to the out-of pocket costs incurred by students who are covered by their school’s student health plans,” Landman said.

Mentavi also addressed many issues that colleges and universities struggle to manage. First, its
diagnoses for ADHD, anxiety, and depression stand up to clinical scrutiny, because they are evaluated by a licensed mental health professional and based on clinical frameworks.

Mentavi’s process also is developed with diversity, equity and inclusion (DEI) considerations, such as whether assessment language penalizes some populations, and whether the summary report and
communication consider the diverse backgrounds and specialized needs of the entire student population.

Universities’ athletic departments are using Mentavi’s Diagnostic Evaluation to document a valid diagnosis of a condition that may require a student-athlete to take a medication that could otherwise
disqualify them from competition under NCAA guidelines.

Colleges also are concerned about the introduction and proper use of certain prescription medications on campus. Mentavi’s assessments can reduce risks of medication diversion and improper use of prescribed substances.

“With Mentavi’s assessment, the institution can maintain control over how medications are being prescribed and administered, and the student can minimize their out-of-pocket costs for appropriate medical treatment,” Gutwald said. “Mentavi is proving to be an effective partner for higher education, both in holding down costs and in ensuring that all students have their best chance for success.”

For more information, visit https://mentavi.com.

About Mentavi Health and ADHD Online
Mentavi Health was launched as ADHD Online (adhdonline.com) in 2018 with the mission that everyone should have access to quality ADHD assessments from a licensed psychologist regardless of
who and where they are. As the reach has expanded to address diagnosis and, in some cases, treatment of ADHD and adjacent mental health conditions, ADHD Online is now a brand under Mentavi Health. The Mentavi Diagnostic Evaluation is offered nationwide, with treatment options available in 40 states.

Source: ADHD Online

About ADHD Online LLC
ADHD Online was founded in 2018 and filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services.
https://adhdonline.com/ | Media Room

Company Address
ADHD Online LLC
625 Kenmoor AVE SE (STE 301)
Grand Rapids, MI 49546
United States

Original Source: www.newswire.com

Dr. Barry K. Herman, not involved in the study but a chief medical officer for ADHD Online, observed that the error increase has been steady over two decades, attributing it to the rising number of ADHD medication prescriptions. He also provided a crucial insight into the dangers of these errors, warning, “Doubling up on psychostimulants… can definitely cause distressing side effects.” Furthermore, he emphasized the risks of non-stimulant ADHD medications, which can lead to significant health issues.

Both experts underscored the importance of patient and caregiver education, with Herman suggesting the transition to unit-dose packaging and the use of tracking apps as potential solutions.

The alarming rise in ADHD medication errors is a pressing concern for parents, caregivers, and healthcare professionals. This article sheds light on the gravity of the issue, offers expert insights, and suggests preventive measures, making it a must-read for those involved in the care of ADHD patients.

Source: Fox News Article

Addressing the ongoing medication shortage, especially of Adderall, Dr. Herman believes the introduction of these generics will be beneficial. He also highlighted the cost benefits, noting that the presence of multiple manufacturers would drive prices down. Concluding on the timely significance of this approval, Dr. Herman remarked, “Having a generic drug available that is approved for both ADHD ages 6 and up, and for adults with moderate to severe binge-eating disorder, could not come at a more opportune time.”

This article sheds light on a crucial development in the healthcare sector, especially for those affected by ADHD medication shortages. It provides insights from experts like Dr. Herman, helping readers understand the implications of the FDA’s decision, both in terms of medical efficacy and economic impact. Reading it offers a comprehensive understanding of the current landscape of ADHD medication and the promising steps being taken to address its challenges.

For the complete article and more details, visit Fox News.

The formation of the new corporate entity is a strategic step taken by Mentavi Health and ADHD Online to enhance its operations and open doors for further expansion. This new structure will allow for a more streamlined business approach, enhanced legal and financial efficiency, and potential partnerships that can enhance the company’s growth trajectory.

In addition, the company has secured a Series AA round of funding from notable investors led by Wakestream Ventures, including Michigan Capital Network, and Boomerang Ventures. This provides the resources to amplify its innovation, expand its reach, and solidify its position in the mental health assessment and treatment market. The round has closed on $2 million to date.   

“Mentavi Health’s commitment to increasing patient access and quality mental health care resonates deeply with our mission at Boomerang Ventures. We’re excited to provide critical capital and leverage our network to fuel their growth and make a meaningful impact in the healthcare industry,” said Oscar Moralez, Founder & Managing Partner, Boomerang Ventures and Advisory Board Member, Mentavi Health.

The company is proud to welcome Keith Brophy as its new Chief Executive Officer. Keith has been previously serving as COO at the company.  With his notable experience in the healthcare and technology industries, including serving as CEO at Ideomed, Sagestone, and leadership roles at large enterprises, Keith is poised to lead ADHD Online towards its ambitious goals, leveraging his deep patient journey knowledge, dynamic leadership capabilities, and track record of leading scalable innovations in healthcare. 

Speaking about his new role, Keith said, “I’m honored to lead ADHD Online as we navigate this exciting chapter. With our new corporate structure, robust investment backing, and strong team, we are well-positioned to accelerate our mission to help make quality mental healthcare accessible and affordable for all.”

Rounding out the series of strategic developments, ADHD Online has also formed a new board of directors with extensive strength in healthcare, patient journey, and company building.  The board comprises industry leaders and strategic thinkers who will guide the company’s vision and growth. The original founders, Zach Booker and Randy Duthler, MD, who launched the company to provide better ADHD treatment after their own personal experiences with the system, remain on the board to continue to instill vision.  

Board Chair and Investor representative Joe Lampen said: “I am excited to add to the Wakestream Ventures investment in Mentavi Health and poised to help advise the company’s strategy and execution through this next stage of growth.”

GRAND RAPIDS, Mich., July 11, 2023 (Newswire.com) – About 95% of American teens report using a social media platform, with more than a third saying they use it “almost constantly.” Studies show social media use may affect young people’s brain development and make them less happy as teenagers—prompting the U.S. Surgeon General in May to issue a public health advisory on social media use. Mentavi Health has added a validated assessment tool for measuring problematic social media use to its standard ADHD Online assessment process.

Mentavi Health is the parent company of ADHD Online, the industry leader in virtual ADHD assessment and patient care plans. ADHD Online offers HIPAA-secured ADHD assessments online with certified results from licensed psychologists in all 50 states.

The Bergen Social Media Addiction Scale (BSMAS), a six-item questionnaire, is a validated assessment tool used in large- and small-scale medical studies. Mentavi Health added the BSMAS at the
recommendation of new Chief Medical Officer Dr. Barry K. Herman to help patients and others raise their awareness of their habits related to social media.

Herman said the Surgeon General’s Advisory was a wake-up call, informing people that they need to pay more attention to the detrimental effects of social media.

“The Surgeon General’s report underscored that urgent action is needed to understand and minimize harm, creating safer online environments for young people. Our team embraced this need and has fully integrated the Bergen Social Media Addiction Scale into our standard ADHD Online assessment process,” Herman said.

“Although social media addiction does not yet have a formal diagnosis in the industry, our ADHD assessment will now also provide pertinent information on patient tendencies and risks in these areas, in keeping with our philosophy of providing optimal self-awareness,” he said.

The Surgeon General’s report notes that harmful effects of social media addiction include increased anxiety, depression, poor concentration, impaired academic and work performance, and decreased overall satisfaction with life. “This is a growing concern among people of all ages, in an area where many have little insight into their behaviors and where consequences can be significant,” Herman said.

Among the findings in the report, which draws on more than 100 studies from pediatricians, psychologists and other experts:

• Children and young adults spend an average of three hours per day on social media platforms.
• Social media is designed to be addictive, with features like endless scrolling and notifications that grab attention.
• The appeal of social media is linked to innate social instincts and the release of dopamine in the brain, which can lead to habit formation and addiction.
• Harmful effects of social media addiction include increased anxiety and depression, disrupted sleep, inability to concentrate, poor academic and work performance, and less overall satisfaction with life Risk factors for social media addiction include poor emotion regulation, low self-esteem, and limited coping skills.

In addition to preventive measures like digital detoxes and reducing social media usage, treatment for social media addiction may involve various approaches, such as therapy, counseling, support groups, and addressing underlying mental health issues.

Mentavi Health believes ADHD Online’s ability to assess people’s problematic social media use can be
a valuable addition to its mission of making better mental and emotional health available to all, regardless of location or physical access to healthcare professionals.

“We hope that with the addition of the BSMAS, we will be able to help even more people develop a better understanding of their overall mental health and to assist our licensed professionals to diagnose, care and connect people with the treatment they need and deserve,” said Herman.

For more information, please visit https://adhdonline.com.

About ADHD Online

ADHD Online was founded in 2018 with the mission that everyone should have access to quality ADHD assessments regardless of who and where they are. The ADHD Online team is filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services. ADHD Online is leading the way with being a critical voice for those who might be struggling with ADHD and is the only organization to offer HIPAA-secured ADHD assessments online with certified results from licensed psychologists. ADHD Online is active in all 50 states.

Source: ADHD Online

About ADHD Online LLC
ADHD Online was founded in 2018 and filled with industry experts across the United States who all share the same passion for ADHD and making sure patients have access to critical mental health services.
https://adhdonline.com/ | Media Room

Company Address
ADHD Online LLC
625 Kenmoor AVE SE (STE 301)
Grand Rapids, MI 49546
United States

Original Source: www.newswire.com